NRx
NRx is a Delaware-based clinical-stage biopharmaceutical company that researches and develops therapeutics for the treatment of suicidal depression and PTSD.
Business Model:
Revenue: $239k
Employees: 11-50
Rankings
Industries / Tags:
Detailed NRx Information
Geographic Data
Address: 1201 N Market Street
City: Wilmington
State: DE
Zip: 19801
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$11M
Raised Total:$66M
Social
Metrics
2,613,494Website Global Rank
5,579Website Monthly Traffic
Twitter Followers
Description
NRx is a Delaware-based clinical-stage biopharmaceutical company that researches and develops therapeutics for the treatment of suicidal depression and PTSD.
Contact Phone:
+14842546134
Contact Email:
NRx went public on 5/25/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/25/2021
Ticker Symbol:
NRXP
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2022 | Post-IPO Debt | 1 | $11M |
Streeterville Capital Streeterville Capital |
8/2021 | Post-IPO Equity | $30M | 1/2022 | Post-IPO Equity | $25M | 5/2015 | Seed Round | $1M | 5/2021 | IPO SPAC | - | 11/2016 | Series B | $9.3M | 2/2022 | Private Placement | $25M | 3/2018 | Series C | 1 | $15.5M |
Kinled Holding Kinled Holding |
5/2021 | IPO SPAC | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
